Avatrombopag clinical trials
Also written E5501, Doptelet and AKR-501.
How each study uses avatrombopag is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the avatrombopag studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 21 May 2018 · DOPTELET · NDA 210238 (FDA, Drugs@FDA)
- European Union
- 20 Jun 2019 · Doptelet · EMEA/H/C/004722 (EMA)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
52 studies that test it; most in 2021 (10)
| Year | Studies |
|---|---|
| 2007 | 2 |
| 2009 | 1 |
| 2010 | 3 |
| 2011 | 3 |
| 2012 | 3 |
| 2013 | 3 |
| 2014 | 2 |
| 2016 | 1 |
| 2018 | 2 |
| 2020 | 2 |
| 2021 | 10 |
| 2022 | 9 |
| 2023 | 3 |
| 2024 | 3 |
| 2025 | 3 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 25 · Other 27
Eisai Inc. (16) · Institute of Hematology & Blood Diseases Hospital, China (9) · Sobi, Inc. (6) · Peking Union Medical College Hospital (3) · Eisai Co., Ltd. (2) · Hanny Al-Samkari, MD (1) · Anhui Provincial Cancer Hospital (1) · University of Virginia (1)
Often tested with
Tested in the same studies.
Tretinoin (1) · Rituximab (1) · Platelet Transfusion (1) · Medication (1)
Studies
Open first, then newest update. How each study uses avatrombopag is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 52
- Time-limited Treatment With Avatrombopag Pre- and Post-CAR T-cell Therapy to Prevent Post-CAR T-cell CytopeniasNot yet recruitingPhase 2University of VirginiaNCT07895017Written as Avatrombopag
- A Study of Avatrombopag in Adults With Aplastic Anemia Who Did Not Respond to, Cannot Receive, or Had Return of Disease After Standard TreatmentNot yet recruitingPhase 2/3Swedish Orphan BiovitrumNCT07786922Written as Avatrombopag 20 mg Oral Tablet
- Avatrombopag Combined With All-trans Retinoic Acid in the Treatment of Primary Immune ThrombocytopeniaNot yet recruitingPhase 2/3Institute of Hematology & Blood Diseases Hospital, ChinaNCT07278908Written as Avatrombopag+All trans retinoic acid
- The Holistic StudyNot yet recruitingPhase 3Ostfold Hospital TrustNCT07051915Written as Avatrombopag
- Exploring the Efficacy, Safety of a Modified Starting Dosage of Avatrombopag in Immune Throbocytopenia (ITP) - a Pilot StudyRecruitingPhase 4Al-Mustansiriyah UniversityNCT07133659Written as Avatrombopag 20 mg Oral Tablet
- Avatrombopag for Chemotherapy-induced ThrombocytopeniaRecruitingPhase 2Institute of Hematology & Blood Diseases Hospital, ChinaNCT05218226Written as Avatrombopag
- Avatrombopag in the Treatment of Pediatric Immune ThrombocytopeniaRecruitingPhase 2Institute of Hematology & Blood Diseases Hospital, ChinaNCT06281327Written as Avatrombopag
- Avatrombopag in the Treatment of Adult Immune Thrombocytopenia With AutoantibodiesRecruitingPhase 2Institute of Hematology & Blood Diseases Hospital, ChinaNCT04993885Written as Avatrombopag
- Efficacy and Safety of Avatrombopag in the Treatment of Thrombocytopenia After Haplo-HSCTRecruitingPhase 2/3Peking University People's HospitalNCT06202625Written as avatrombopag
- Efficacy and Safety of Avatrombopag vs. Avatrombopag Combined With rhTPO in the Treatment of SAANot yet recruitingPhase 2Institute of Hematology & Blood Diseases Hospital, ChinaNCT06254287Written as Avatrombopag
- Efficacy and Safety of CsA+AVA in the Treatment of NSAA in the ElderlyRecruitingPhase 2Peking Union Medical College HospitalNCT06004752Written as Avatrombopag
- Avatrombopag for HCC Patients With Thrombocytopenia Who Intend to Undergo TACE and/or HAICRecruitingPhase 2Second Affiliated Hospital of Guangzhou Medical UniversityNCT06001567Written as Avatrombopag
- The Safety and Efficacy Study of Avatrombopag Switch in TPO-RA Refractory AARecruitingNot applicableInstitute of Hematology & Blood Diseases Hospital, ChinaNCT05518331Written as avatrombopag
- Avatrombopag vs. Placebo for CIT in GI MalignanciesCompletedPhase 2Hanny Al-Samkari, MDNCT05772546Written as Avatrombopag
- Avatrombopag for the Treatment of Thrombocytopenia in Pediatric Subjects With Immune Thrombocytopenia for ≥6 MonthsCompletedPhase 3Sobi, Inc.NCT04516967Written as Avatrombopag
- Evaluation of Avatrombopag for the Treatment of Thrombocytopenia in Japanese Adults With Chronic ITPCompletedPhase 3Sobi, Inc.NCT05369208Written as Avatrombopag Oral Tablet
- Safety and Treatment Satisfaction in Adults With Chronic ITP After Switching to Avatrombopag From Eltrombopag or RomiplostimCompletedPhase 4Sobi, Inc.NCT04638829Written as Avatrombopag Oral Tablet
- Study of Avatrombopag for Temozolomide-induced Thrombocytopenia in Glioma (APATIT-G)WithdrawnEarly Phase 1University of RochesterNCT04931849Written as Avatrombopag
- Avatrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Adults With Active Non-Hematological CancersCompletedPhase 3Sobi, Inc.NCT03471078Written as Avatrombopag
- Avatrombopag Combined With IST as First-line Treatment for SAAStatus unknownPhase 2Institute of Hematology & Blood Diseases Hospital, ChinaNCT05720234Written as avatrombopag
See all 52 studies that test avatrombopag →
Given beside what is tested · 1 — avatrombopag is usual care or a partner of the new treatment
What changed recently
From the registry's own updates since Oct 18, 2026.
Newly registered1
Codes
What other systems call avatrombopag · ClinicalTrials.gg INT005355
- MeSH (NLM) C533238avatrombopagConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) 3H8GSZ4SQLAVATROMBOPAGConfirmed FDA, NLM, Wikidata
- RxNorm 2045726One source FDA
- Wikidata Q27257213avatrombopagConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C150559AvatrombopagOne source FDA
- DrugBank DB11995One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C533238 | avatrombopag | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 3H8GSZ4SQL | AVATROMBOPAG | Confirmed FDA, NLM, Wikidata |
| RxNorm | 2045726 | — | One source FDA |
| Wikidata | Q27257213 | avatrombopag | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C150559 | Avatrombopag | One source FDA |
| DrugBank | DB11995 | — | One source Wikidata |
Also registered as avatrombopag maleate (UNII GDW7M2P1IS · RxNorm 2045727).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.